American Research & Management Co. Gilead Sciences, Inc. Transaction History

American Research & Management Co.

$362 Million
Q3 2022

A detailed history of American Research & Management Co. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, American Research & Management Co. holds 35,315 shares of GILD stock, worth $2.96 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares

35,315

Previous 36,992 4.53%

Holding current value

$2.96 Million

Previous $2.29 Million 4.68%

% of portfolio

0.6%

Previous 0.59%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 07, 2022	SELL	$59.54 - $68.01 $99,848 - $114,052	-1,677 Reduced 4.53%	35,315 $2.18 Million
Q2 2022 Jul 22, 2022	SELL	$57.72 - $65.01 $55,468 - $62,474	-961 Reduced 2.53%	36,992 $2.29 Million
Q1 2022 Apr 21, 2022	SELL	$57.92 - $72.58 $254,210 - $318,553	-4,389 Reduced 10.37%	37,953 $2.26 Million
Q4 2021 Jan 28, 2022	SELL	$64.88 - $73.64 $45,351 - $51,474	-699 Reduced 1.62%	42,342 $3.07 Million
Q3 2021 Oct 28, 2021	SELL	$67.69 - $73.03 $189,464 - $204,410	-2,799 Reduced 6.11%	43,041 $3.01 Million
Q2 2021 Jul 16, 2021	BUY	$63.47 - $69.35 $18,088 - $19,764	285 Added 0.63%	45,840 $3.16 Million
Q1 2021 Apr 06, 2021	SELL	$60.0 - $68.46 $26,640 - $30,396	-444 Reduced 0.97%	45,555 $2.94 Million
Q4 2020 Jan 28, 2021	BUY	$56.65 - $64.55 $1.79 Million - $2.03 Million	31,516 Added 217.61%	45,999 $2.68 Million
Q3 2020 Oct 29, 2020	SELL	$62.1 - $78.08 $3,105 - $3,904	-50 Reduced 0.34%	14,483 $915,000
Q2 2020 Jul 28, 2020	BUY	$72.34 - $84.0 $217 - $252	3 Added 0.02%	14,533 $1.12 Million
Q1 2020 Apr 28, 2020	SELL	$62.63 - $80.22 $31,315 - $40,110	-500 Reduced 3.33%	14,530 $1.09 Million
Q4 2019 Jan 17, 2020	SELL	$61.62 - $67.78 $175,617 - $193,173	-2,850 Reduced 15.94%	15,030 $977,000
Q3 2019 Oct 31, 2019	SELL	$62.51 - $69.0 $140,647 - $155,250	-2,250 Reduced 11.18%	17,880 $1.13 Million
Q2 2019 Jul 18, 2019	SELL	$61.87 - $69.38 $65,582 - $73,542	-1,060 Reduced 5.0%	20,130 $1.36 Million
Q4 2018 Feb 12, 2019	SELL	$60.54 - $79.0 $434,071 - $566,430	-7,170 Reduced 25.28%	21,190 $1.33 Million
Q3 2018 Oct 04, 2018	BUY	$71.28 - $78.92 $62,726 - $69,449	880 Added 3.2%	28,360 $2.19 Million
Q2 2018 Jul 25, 2018	BUY	$64.88 - $75.68 $358,786 - $418,510	5,530 Added 25.19%	27,480 $1.95 Million
Q1 2018 Apr 19, 2018	BUY	$72.84 - $88.8 $119,093 - $145,188	1,635 Added 8.05%	21,950 $1.66 Million
Q4 2017 Feb 08, 2018	BUY	$71.15 - $83.52 $53,006 - $62,222	745 Added 3.81%	20,315 $1.46 Million
Q3 2017 Oct 17, 2017	BUY	$72.11 - $85.47 $1.41 Million - $1.67 Million	19,570	19,570 $1.59 Million

Others Institutions Holding GILD

# of Institutions

1,878

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Research & Management Co., based on Form 13F filings with the SEC.

News

Stay updated on American Research & Management Co. with notifications on news.

Account

American Research & Management Co. Gilead Sciences, Inc. Transaction History